Vantage Consulting Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,248
Closed -$67K 465
2020
Q4
$67K Buy
+3,248
New +$67K 0.01% 338